PDB14 COST-EFFECTIVENESS OF MONO- AND COMBINATION THERAPY WITH PIOGLITAZONE COMPARED TO GLICLAZIDE IN PATIENTS WITH TYPE-2-DIABETES MELLITUS FROM A GERMAN STATUTORY HEALTH CARE PERSPECTIVE
| Autor: | O Mast, G Lübben, K Neeser, A Lütke, Wendelin Schramm |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
medicine.medical_specialty
Combination therapy business.industry Cost effectiveness Health Policy Perspective (graphical) Public Health Environmental and Occupational Health Type 2 Diabetes Mellitus language.human_language German Health care medicine Physical therapy language Gliclazide Intensive care medicine business Pioglitazone medicine.drug |
| Zdroj: | Value in Health. 7(6) |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/s1098-3015(10)65957-8 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect